TP53INP2 and melanoma: Overexpression of miR‐638 is reported in metastatic lesions compared with primary melanomas; it downregulates the TP53INP2 oncosuppressor and thereby protects melanoma cells from apoptosis and autophagy (Bhattacharya et al., 2015).